Here’s the list of best cancer hospitals in the world. The list is very carefully prepared keeping in mind use of latest technology to treat cancer, ongoing research projects in the hospital, ongoing clinical trials in the hospital, total of doctors and paramedic staff, number of beds & number of patients treated per year with success. So here is the list of best cancer hospitals in the world.
Here are the best cancer hospitals in the world
University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Expertise of MD Anderson
MD Anderson focus entirely on cancer and have seen cases of every type. Doctors at MD Anderson treat more rare cancer in a single day than most physicians see in a lifetime. That means you receive professional care. MD Anderson is among the largest cancer centers in the world. MD Anderson has been working on cancer cure and research for more than 7 decades. MD Anderson extent of experience endows to every aspect of your care. MD Anderson have been ranked as one of the top two hospitals in cancer care every year since U.S. News & World Report began its annual “America’s Best Hospitals” survey in 1990. MD Anderson physicians are frequently regarded as among the best in the nation by services including Best Doctors in America. MD Anderson have more nurses per patient than many hospitals in the country, so you receive the utmost engrossment and quality care.
The use and advancement of state-of-the-art diagnostic technologies is world-acclaimed by MD Anderson. That helps doctors to recognize the particular cancer of each patient and formulate a personalized treatment plan according to individual needs. MD Anderson has been ranked by the United States as the No. 1 cancer care hospital in the world. “Best Hospitals” survey by News & World Report.
Ingenious research at MD Anderson
One of the greatest strengths of MD Anderson is its ability to turn the most promising laboratory discoveries of today into the modern, more efficient and less stressful therapies of tomorrow. Over the years, MD Anderson has discovered myriad medical advancements. By obtaining not just the best therapies to depreciate or kill their cancer, MD Anderson patients benefit from the study.
New and ingenious treatments are normally available several years before they become commonplace in the culture at MD Anderson. They integrate state-of-the-art patient treatment in their clinical trials, thus estimating the latest developments in cancer medicine. For problematic or combative tumors, they often provide therapeutic options.
MD Anderson ranks first in the number of research grants awarded by the National Cancer Institute. By studying how cancer begins and responds to various treatments, we can help patients overcome disease and prevent cancer appearing again. Because of all the reason above this cancer center can easily be the best cancer hospital in the world.
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
On August 8, 1945, the Sloan-Kettering Institute for Cancer Research (SKI) was founded. The introductory funds for the construction of the institute and its early running costs were arranged by a $4 million donation from Alfred P. Sloan, Jr., Chairman of General Motors and a trustee on the Memorial Hospital board. The Institute’s co-founder was Engineer Charles F. Kettering, GM’s Director of Research and inventor of the key-operated ignition switch and anti-knock gasoline. He worked for several years as a member of SKI’s Committee on Science Policy.
As its founders conceived, SKI would be committed exclusively to scientific research and would play a crucial role in the academic life of the cancer center.
“In 1945, Reginald Coombe, President of Memorial, said, “The building of the Sloan-Kettering Institute will stand squarely in the middle of the Memorial Cancer Center. “It will occupy the dominant place that research in such a center should occupy.”
“In 1945, Reginald Coombe, President of Memorial, said, “The building of the Sloan-Kettering Institute will stand squarely in the middle of the Memorial Cancer Center. “It will occupy the dominant place that research in such a center should occupy.”
“The Sloan-Kettering Institute building will stand squarely in the middle of Memorial Cancer Center,” Reginald Coombe, Memorial’s President, said in 1945. “It will occupy the dominant place that research should occupy in such a Center.”
The New York Times covered the development on its front page. The announcement, which came two days after the bombing of Hiroshima in 1945, noted that like the research program that developed the atomic bomb, research efforts that were “scientifically organized” could make rapid progress — in this case in the fight against cancer.
As the experimental research arm of Memorial Sloan Kettering Cancer Center, SKI is focused on the pursuit of fundamental scientific discoveries. The institute’s philosophy is that the best way to fuel progress in cancer treatment is to support scientists as they explore the unknown.
SKI is distinguished by its:
- world-renowned faculty
- cutting-edge technological resources
- relatively small size and open academic community
- extensive collaboration between scientists and clinicians
Within the overarching association of scholars, physicians, and researchers that make up MSK, SKI exists as a perspicuous organization. There are more than 100 paramedic laboratory personnel at the Sloan Katterring Institute, 400 post-doctoral research scientists, and more than 300 PhD / MD / graduates. The institute maintains a friendly friendship with Weill Cornell Medicine and Rockefeller University neighbors.
SKI has made many advancements in our knowledge of biology and medicine over the course of its 70-year history. SKI scientists have discovered cancer-related genes, unraveled signaling pathways that underlie the growth and division of cells, and identified the types of cells involved in immune responses mounting and repressing. SKI research, from chemotherapy to targeted therapy to immunotherapy, has also been a driver of clinical developments in cancer care.
In their fields, SKI scientists are pioneers. Several are members of the National Academies of Science and Research. Many are investigators for the Howard Hughes Medical Institute. They are the winners of many distinctions and prizes. And so it is easy to name SKI the world’s best cancer hospital.
Top cancer hospitals in the world
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
There are 12 site groups and 26 specialty clinics at the Princess Margaret Cancer Centre, and more than 3,000 employees who see over 400,000 patients per year. 202 hospital beds, 16 linear accelerators, a state-of-the-art Magnetic Resonance-guided Radiation Therapy (MRgRT) suite, and two Leksell Gamma Knife Perfexion units are 850,000 square feet of clinical space, making it one of the world’s most comprehensive cancer care facilities and Canada’s largest radiation treatment facility.
Every day, Princess Margaret sees over 1,000 patients and has the capacity to provide nearly 200,000 patients and their families with diagnostic, medication, and follow-up care every year. We saw 17,751 new patients in 2016. We delivered 6,031 cancer surgeries, as well as 37,754 device therapy visits, 91,517 radiation visits, and 428 stem cell transplants, among the services rendered this past year.
Princess Margaret continues to be on the frontiers of medical, surgical and radiation oncology through ongoing research, education and creativity, promoting the latest technologies and international best-practices and setting standards for patient care.
Princess Margaret History
The Princess Margaret Hospital was established in 1952 by the Ontario government as the Ontario Cancer Institute. Originally located in Toronto at 500 Sherbourne Lane, the hospital was formally opened by Her Royal Highness Princess Margaret in 1958 and, to mark the occasion, was renamed Princess Margaret Hospital.
In 1996, at its new location on University Avenue, the heart of Canada’s innovation center and the largest concentration of teaching and research hospitals in the world, the hospital officially re-opened. Once again, Her Royal Highness Princess Margaret was there to formally reopen the 130-bed cancer center.
The Princess Margaret Hospital became part of the University Health Network in 1998, combining Toronto General and Toronto Western hospitals’ oncology programs with Princess Margaret’s, making Princess Margaret Hospital the country’s most integrated cancer program.
In 2012, Princess Margaret Hospital was renamed the Princess Margaret Cancer Centre.
Asan medical center, Seoul, South-Korea
By upholding the values of “Respect for Life” and “Sharing Pain with Neighbors,” Asan Medical Center has also fulfilled its social obligation as “Korea’s Most Respected Hospital.”
With advanced technology and medical expertise on par with other top hospitals in the globe, Asan Medical Center is driving Korea’s medical advancement.
Among the eight hospitals run by the ASAN Foundation, Asan Medical Center serves as the “parent” facility. The ASAN Foundation has offered non-profit initiatives in academic research, scholarship, and social and medical welfare since it was founded in 1977. In order to carry forth the founder’s vision of “helping the neediest in our society,” the ASAN Foundation opened hospitals in remote areas with a dearth of contemporary medical services.
The late Chairman Chung turned his attention to social issues
when most other Korean businesses were focusing solely on profits.
By expanding corporate values to include not only how a company makes money but also where it spend its profits, the late chairman moved to implement his belief that a business should contribute to the well-being of society. Such a belief is the ASAN Foundation’s founding principle.
By launching non-profit programs in the areas of medical resources, social welfare, R and D, and scholarships, he set valuable examples on how corporate citizenship can ease the pain of the needy and raise the quality of people’s lives.
Now with this great man gone, all of us at the ASAN Foundation solemnly pledge to follow his spirit of love for mankind and to apply that spirit to society’s pressing needs.
Asan Medical Center is housed within the ASAN Foundation, which was founded in 1977 with private funds donated by late founder Chung Ju-yung. The ASAN Foundation has started a number of welfare projects in the fields of social welfare, scholarship, research, and medical care in the past when people were not familiar with the term “welfare”. The ASAN Foundation has established hospitals in doctor-less areas around the country with a special focus on medical projects to enable everyone to equally access medical care.
In addition, the Asan Medical Center was established on June 23, 1989 as the mother hospital of the local medical facilities with the objective of building a top-notch facility that would raise the level of healthcare in Korea as a whole.
The objective of Asan Medical Center is to “contribute to the healthy life of humanity by delivering high-quality medical services, education, and research with unrelenting passion and challenges,” and more effort has been put into achieving this goal. Because of the innovative medicines we have created over the past 20 years that have overcome the drawbacks of traditional medicine, we have been recognised as Korea’s most admired hospital for 14 years running.
Through the use of an emergency response system and criteria for evaluating medical treatment, we have innovated our entire process to turn into a hospital that is patient-centric. This has improved patient safety and the calibre of medical services. We also work hard to develop a distinctive culture in which patient feedback informs medical care.
By continuing to work to advance medical education, raise the bar for clinical care, and offer cutting-edge, compassionate healthcare, Asan Medical Center pledges to do its best to become the most reputable hospital and a pioneer in Korean medicine and healthcare.
Hospital of the University of PA Abramson Cancer Center, Philadelphia, PA, United States
The Abramson Cancer Center at Penn Medicine is a global leader in cancer research, patient care and education. They are classified as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 47 such centers in the United States, our preeminent position is reflected.
They are committed to creative and compassionate cancer treatment at the Abramson Cancer Center. Their clinical service, consisting of a committed team of doctors, counselors, nurses, social workers, physical therapists, nutritionists and coordinators of patient care, currently has 230,000 hospital visits and more than 11,800 discharges, delivering more than 37,000 chemotherapy and 66,000 radiation treatments.
Not only are they committed to delivering state-of-the-art services, with more than 8,000 participants in almost 600 clinical trials, the new models of cancer prevention, diagnosis and treatment are accessible to their patients through clinical themes created through the constant pursuit of reducing the pain and suffering from cancer.
Furthermore, the Abramson Cancer Center is home to more than 400 fundamental, translational and clinical scientists who work tirelessly to establish cancer pathogenesis. Together, our faculty is committed to enhancing cancer prevention, diagnosis and care. Founded in 1973, the Abramson Cancer Center provides the newest and most groundbreaking treatment developments for cancer patients. The leadership team of the Abramson Cancer Center consists of scientists, doctors, and managers who are world leaders in their respective fields. The Abramson Cancer Center of Penn Medicine is home to clinical departments and divisions that share the goal of enhancing the future of cancer treatment.
Sheba Medical Center, Cancer Center, Tel Aviv, Israel
In addition to being part of Israel’s largest hospital, the Cancer Center at Sheba Medical Center is the absolute pioneer in cancer care in Israel.
In battle against cancer, Sheba took a genuinely holistic approach, putting patients first and delivering many support programs for not only their medical requirements, but for their psychological, social, and palliative needs.
For each and every one of their patients, their guiding principles cover complete treatment. This ensures that for their patients and their families, they have specialist who are competent, and provide compassionate care. As the country’s first facility to deliver a fully holistic approach to cancer care in Israel, Tal Center for Integrative Medicine reflects this dedication. While all of their therapies are rooted in clinically validated evidence, in addition to the new, cutting edge Western medicine, they have made alternative treatments accessible.
These complementary treatments include physiotherapy, support from nutritionists, and a professional and caring nursing staff. Psychological services are also provided as they understand that state of mind and mental health has a profound impact on physical health.
Cancer is not a punishment or a fate for their patients. They truly believe that their patients can combat even the most serious disease and maintain a decent quality of life, with integrative medicine incorporating the latest in technology and medical science with compassion and experience. A vital component of our overall dedication to our patients is our stellar staff. Both our doctors are specialists in their field and have advanced training and experience in the treatment of various forms of cancer. We are proud of having many of Israel’s most qualified physicians and surgeons, and we still take a multidisciplinary approach to patient care. As we make correct diagnosis and form customized treatment plans consisting of immunotherapy, surgery, radiotherapy, and chemotherapy, teamwork and cooperation are essential.
Roswell Park Cancer Institute, Buffalo, NY, United States
Established in 1898 as the first cancer center in the country, Roswell Park set the standard for today’s multidisciplinary approach to cancer treatment of the highest quality. Roswell Park was named the Best Cancer Hospital for 2019-20 by the U.S. News & World Report and is known for colon and lung cancer surgery as high-performing.
The Roswell Park Comprehensive Cancer Center is one of a small few to hold the “Comprehensive Cancer Center” designation of the National Cancer Institute and the only one outside New York City in New York State. This designation indicates that the combined science, care and educational services of a cancer center have weathered comprehensive peer scrutiny, met stringent national standards, and made important contributions to reducing the burden of cancer.
In 1974, Roswell Park was among the first to be accredited as a Comprehensive Cancer Center by the NCI and has since served as a national model.
Roswell Park is also part of the National Comprehensive Cancer Network (NCCN), an alliance of the leading cancer centers in the world. The NCCN, a non-profit organization, brings together the best science minds to create continuous quality improvements in cancer care; enhance the efficiency of cancer care delivery through the ongoing collection and review of data on national results; improve coordination and cooperation between member institutions; provide access to the new, most successful clinical trials; and measurement tools.
Roswell Park has achieved accreditation from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) as a result of its demonstrated compliance with the Joint Commission’s nationally recognized health care standards.
Accreditations, Certifications & Membership
Roswell Park holds accreditations or certifications from many organizations, including:
- Accreditation Council for Continuing Medical Education
- Accreditation Council for Graduate Medical Education – for Medical and Surgical Oncology Training Programs
- American College of Radiology Breast Imaging Center of Excellence
- American Dental Association – Dentistry and Maxillofacial Prosthetics
- Association for the Accreditation of Human Research Protection Programs
- Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International)
- American Association of Blood Banks (AABB)
- Blue Distinction Center for Cancer Care
- Blue Distinction Center for Cellular Immunotherapy
- Blue Distinction Center for Transplants
- Cancer Immunotherapy Trials Network Member (CITN)
- Commission on Cancer of the American College of Surgeons
- Forbes Best Employers for Diversity
- Foundation for the Accreditation of Cellular Therapy (FACT)
- Lung Cancer Alliance Screening Center of Excellence
- National Accreditation Program for Breast Cancers (NAPBC)
- National Cancer Institute-designated Comprehensive Cancer Center
- National Comprehensive Cancer Network (NCCN)
- National Marrow Donor Program
- New York State Department of Health
- Optum® Cancer Center of Excellence (COE)
- Quality Oncology Practice Initiative (QOPI) Certification from the American Society of Clinical Oncology (ASCO)
- The Joint Commission
- The Joint Commission Certification for Palliative Care
- The Joint Commission Laboratory Accreditation
John Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States
The name Johns Hopkins has become synonymous with excellence in research and patient care. Its science and medical programs earn more federal research dollars than any other medical institution in the country.
Since its opening in 1973, our Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to treat it. The strength of our research and treatment programs was recognized early on by the National Cancer Institute, becoming one of the first to earn comprehensive cancer center status and recognition as a “Center of Excellence.”
The Johns Hopkins Kimmel Cancer Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control.
Why Johns Hopkins?
Patients who visit the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have access to some of the most innovative and advanced therapies in the world. Because Kimmel Cancer Center clinicians and research scientists work closely together, new drugs and treatments developed in the laboratory are quickly transferred to the clinical setting, offering patients cutting edge therapeutic options.
The Kimmel Cancer Center has a wide spectrum of specialty programs for both adults and children coping with cancer, including bone marrow transplantation (BMT) and new drug development. Additionally, those at high risk for developing breast, ovarian, colon and other cancers, may seek information about early detection, prevention and genetic counseling through a comprehensive genetics service.
We also offers complete family and patient services that include a Cancer Counseling Center, survivors and palliative care programs, and two residences for patients traveling from out-of-town to receive treatment.
The Kimmel Cancer Center furthered its commitment to excellence in patient care and offer cancer care at may facilities throughout Maryland and the National Capital Region.
Apollo Cancer Hospital & Apollo Proton Centre, Chennai, India
Apollo Cancer Centre, India’s first ISO certified healthcare provider is today ranked among the top super specialty hospitals , offering advanced tertiary care in Oncology, Orthopedics, Neurology and Neurosurgery, Head and Neck surgery and Reconstructive and Plastic surgery.
Equipped with 300 beds, the latest and the best technology, manned by a large pool of world renowned specialists and supported by a dedicated team of medical and paramedical professionals, Apollo Cancer Centre offers specialty healthcare of international standards with outcomes matching those of the world’s best hospitals.
The hospital provides 360 degree cancer care. The comprehensive treatment planning system involves a Tumour Board which consists of a panel of competent medical, surgical and radiation oncologists. The Board along with diagnostic consultants examines referred cases and jointly decides on the best line of treatment for each patient. Medical counsellors, speech therapists, dieticians and other professionals, relevant to the case further support the panel.
The hospital is one of the few centers in India with facilities to search for a potential unrelated donor and offer transplantation.
- First Oncology Hospital in India and First Hospital in Chennai city to be accredited by NABH.
- First hospital in South-East Asia to introduce the 64 Slice PET-CT Scan.
- First hospital in India to introduce CyberKnifeÃ‚Â®.
- First hospital in India to have all the latest Radiotherapy equipment such as TrueBeam STX .
- First hospital in India to launch Proton Therapy shortly.
- Full Field Digital Mammography with Tomosynthesis (3D) System.
- 64 SLICE- PET CT scan system.
- PET CT MRI
- True Beam STX radiotherapy
- Proton therapy
- 300 Beds
- Dedicated Chemotherapy Ward
- Dedicated Stem Cell Transplant Unit
- Platinum Ward Dedicated To Patient Comfort
Apollo Proton Cancer Centre, Chennai, India
The Apollo Proton Cancer Centre (APCC) is a 150-bed integrated cancer hospital that offers state-of-the-art comprehensive cancer care. It is South East Asia’s first Proton Therapy and a major milestone in India’s concerted focus to battle and conquer cancer. Powered by a cutting-edge multi room Proton Centre, APCC is revolutionizing radiation oncology not just in India, but across the region. The hospital is a beacon of hope for over 3.5 billion people.
The advanced Proton Therapy at APCC is complemented by a fully integrated treatment suite that offers the most advanced treatment procedures in surgical, radiation, medical oncology. True to the Apollo Pillars of Expertise and Excellence, the Centre brings together a powerful medical team helmed by some of the influential names in cancer care.
At the bedrock of APCC’s approach to treat cancer is its robust multi-disciplinary platform; highly skilled professionals – united by expertise and commitment – come together to form Cancer Management Teams (CMT). Each CMT is focused on delivering the best possible outcomes to their patients.
USC Norris Comprehensive Cancer Center, Los Angeles, CA, United States
The USC Norris Comprehensive Cancer Center, located in Los Angeles, is a major regional and national resource for cancer research, treatment, prevention, and education.
More than 200 basic and population scientists, physicians from the faculty of the Keck School of Medicine of USC, and several USC professional schools/departments and the College of Letters, Arts and Sciences who are members of the USC Norris Comprehensive Cancer Center investigate the complex origins and progression of cancer, develop prevention strategies, and search for cures.
The National Cancer Institute (NCI) has designated the USC Norris Comprehensive Cancer Center as one of the nation’s 51 comprehensive cancer centers, a select group of institutions providing leadership in cancer treatment, research, prevention, and education. USC Norris Comprehensive Cancer Center has held this designation since 1973, when it was named as one of the first eight comprehensive cancer centers.
USC Norris Comprehensive Cancer Center scientists work toward a complete understanding of the most fundamental aspects of cancer. They study the abnormal cell growth characteristics of cancer to determine what goes wrong and how the process can be altered. They then work to quickly translate those findings into treatment and prevention strategies.
Over the years of its history, the Cancer Center has made many important scientific advances including the development of a major classification scheme for lymphoma (Lukes), the discovery of the jun oncogene (Vogt), the elucidation of links between steroid hormones and breast and prostate cancer (Henderson, Ross, Pike, Bernstein, et al), the development of surgical techniques for orthotopic bladder reconstruction (Skinner), the establishment of the relationships between DNA methylation and cancer (Jones and Laird), the roles of glucose regulated proteins in cancer (Lee), the development of molecular markers for neuroblastoma (Seeger), bladder cancer (Cote), GI cancers (Lenz), 8q24’s link to prostate and colon cancer (Haiman, Henderson), and the identification of a key genetic mutation in lymphoma development (Lieber).
Research at USC Norris Comprehensive Cancer Center is organized into five research programs (Translational and Clinical Sciences, Genomic and Epigenomic Regulation, Tumor Microenvironment, Cancer Epidemiology, and Cancer Control Research). of the USC Norris Comprehensive Cancer Center members has been carefully determined to promote the Cancer Center’s overall goal of fostering collaborative research in the areas of basic, clinical, epidemiological, cancer control, and translational research.
USC Norris Comprehensive Cancer Center members currently hold research and industry grants totaling over $135 million in direct costs, with $35 million of that coming from the NCI.
USC Norris Comprehensive Cancer Center provides comprehensive care for patients in its affiliated hospitals and outpatient clinics, and conducts hundreds of clinical trials, offering the latest in innovative cancer treatments. USC Norris Comprehensive Cancer Center affiliated hospitals include the USC Norris Cancer Hospital, Children’s Hospital Los Angeles, Keck Hospital of USC and Los Angeles County + USC Medical Center, one of the largest teaching hospitals in the nation.
At each location, USC Norris Comprehensive Cancer Center physicians and scientists are dedicated to fighting the battle against cancer with patients, their families, and friends.
Tata Memorial Hospital, Mumbai, India
Tata Memorial Centre is amongst the oldest and largest cancer centres in the world, with over 75 years of exceptional patient care, high-quality training and innovative cancer research. Over the years, it has grown in size and stature, maintaining its pre-eminent position at the forefront of national and global cancer control efforts.
Compassionate patient care remains the major focus of Tata Memorial Centre, with eleven Disease Management Groups (or multidisciplinary teams) breaking departmental silos and providing optimal care for every patient. This emphasis on team approach leverages the extensive experience and expertise of various specialists, thereby providing patients with evidence-based, yet individualized care, tailored not just to the cancer but also the patient’s unique physical, emotional and psychosocial needs.
Researchers at the Tata Memorial Centre are world leaders in basic, translational, epidemiologic and clinical cancer research. Research at TMC includes studies to understand cancer biology, large community based screening trials for common cancers and cohort studies, neoadjuvant and adjuvant treatment, perioperative interventions, surgical trials, repurposing drugs and qualitative research to understand the patient journey. Our research focuses on impacting survival and quality of life i.e., living longer, or living better –endpoints that really matter to patients.
Training and education form a major focus area for TMC, which remains the most sought after institution for oncology training nationally. Combining a world-class academic faculty and being amongst the highest volume cancer centres in the world, we take special pride that our alumni now provide specialist oncology care and hold leadership positions in several cancer centres in the country and internationally.
We are grateful to the Department of Atomic Energy, Government of India for their unstinting support over the years, enabling us to respond to changing times and adapting our strategy to the country’s needs. The establishment of the National Cancer Grid is a remarkable example of this foresight and vision – creating the largest cancer network in the world, with over 150 cancer centres, research institutions, patient groups, charitable organizations and professional societies working together to provide uniform standards of cancer care, enhance human resource and conduct collaborative multidisciplinary cancer research within the country and internationally.
As we now embark on a major expansion plan that will quadruple our patient care capabilities as well as broaden our geographic presence in the country, we pledge to bring the same standards for which Tata Memorial Centre is known in each of the new centres, thereby bringing high quality cancer care to several thousand patients at their doorsteps. This is also the opportune time to rededicate ourselves to the strong values and qualities that have characterized our distinguished institution for close to eight decades.
Kings College Hospital, NHS Hospital Trust, London, UK
We are one of London’s largest and busiest teaching hospitals, with a strong profile of local services primarily serving the boroughs of Lambeth, Southwark, Lewisham and Bromley.
Our specialist services are available to patients across a wider catchment area, providing nationally and internationally recognised work in liver disease and transplantation, neurosciences, haemato-oncology and foetal medicine.
Over the last 170 years, King’s has built its reputation as a world class hospital, with roots that lie firmly in the heart of our community. We are both a leading teaching hospital and a local hospital with a diverse inner city population.
Caring for patients from some of the most deprived communities in London, and some of the wealthiest; our world class specialties such as diabetes, liver and sickle cell are largely driven by the health problems of the people around us.
Right from our origins caring for the poor and needy in Lincoln’s Inn, and wounded soldiers from two world wars, the culture at King’s has always been one of creativity and enterprise, and this is reflected in the people we choose to employ.
Wake Forest University Baptist Comprehensive Cancer Center, Winston-Salem, NC, United States
The Wake Forest Baptist Medical Center Comprehensive Cancer Center continues to earn recognition as one of the top institutions of its kind in the country. Our cancer center serves all of North Carolina, including Winston-Salem, Raleigh and Durham and is convenient to access for patients in South Carolina and Virginia.
The center’s designation by the National Cancer Institute (NCI) as a comprehensive cancer center was renewed for five years, making it one of three comprehensive cancer centers in North Carolina, one of 51 in the country and one of the very few to hold the designation continuously since 1990.
The NCI designation means that a Comprehensive Cancer Center meets the highest U.S. government standards for cancer research and patient care. Studies show that patients who receive care at an NCI-designated cancer center can improve their long-term survival rates by up to 25%.
As an NCI-designated Comprehensive Cancer Center, Wake Forest Baptist Health is recognized for the highest levels of expertise and a commitment to patient care, cancer research, including clinical trials, and education. The rapid pace of discovery and the early availability of many new cancer treatments at NCI-designated Comprehensive Cancer Centers, gives us an advantage in offering our cancer patients early access to the latest therapies and treatment options, sometimes even months or years before non-NCI cancer centers.
The Comprehensive Cancer Center has a team of 120 clinicians representing all aspects of cancer care including those in the fields of Hematology and Oncology, Gynecologic Oncology, Radiation Oncology, Surgical Oncology and Colon and Rectal Surgery. These specialists are committed to offering patients the latest treatments, technologies and clinical trials, including precision medicine, cancer genomics, and immunotherapy. The cancer center also provides a range of support programs to help patients and their family members successfully address the various non-medical issues they face while dealing with cancer.
Hayworth Cancer Center in High Point, NC, is part of the Comprehensive Cancer Center system.
Multiple Cancer Specialists Ensure Advanced Treatment
By combining views from multiple cancer experts, our patients can expect to have the best cancer treatment available. This “consensus treatment planning” not only ensures that every possibility is considered for the patient’s health, it streamlines the process to provide answers and care faster. Our multidisciplinary clinics are so effective that patients can see an entire group of physicians who specialize in treating their type of cancer in one day.
Spanish National Cancer Research Center, Madrid, Spain – Centro Nacional de Investigaciones Oncológicas (CNIO)
Here at the CNIO over 400 highly specialized professionals are working to defeat one of the main causes of death in our society. On a global level, we are ranked as one of the best centres specializing in cancer research, a claim that can be gauged by the number and quality of scientific papers accepted for publication in addition to the innovative breakthroughs that pave the way for new drugs and therapies to counter the disease. One of our main objectives is to arrive at an understanding of why cancer occurs in some people and not in others. We are absolutely convinced that only by understanding its whys and how’s can we learn how to prevent it from occurring and, if that cannot be done, detect it and fight back when it appears.
By the same token, CNIO researchers make every effort to ensure that the benefits of their work reach the cancer patient without undue delay. We find compounds that seem likely candidates to be transformed into drugs and can be protected by patent and licensed out to the pharmaceutical industry. We take the lead in supervising clinical trials and do diagnosis and genetic consultation at the request of thousands of families. Moreover, the CNIO has given rise to new biotechnology ventures that create new jobs and also make direct contact with the patients. We have some of the most cutting-edge new technology at our disposal and our constant concern is how best to put it to use.
We are a young institution and a magnet for talented researchers from all over the world. Top drawer scientists and oncologists of the future come to learn at the Centre. Over 60%of our research associates are under age 40 and over 20% of the young people awarded post doctoral contracts come to us from universities outside Spain. It can hardly be emphasized enough that the scientific advances that emerge from the CNIO are largely the work of women, who account for 68% of all scientists. That said, it should be noted that the percentage of women in charge of research projects is under 50%. Accordingly, in 2012 the Office of Women in Science (WISE) was established by the CNIO, aimed at countering the gendered stereotypes we see as the source of the inequality of opportunities between men and women, and from which scientific research is not exempt.
Funding for our research is obtained competitively, rivalling with some of the world’s best and most prestigious institutions, as a guarantee of its quality.
We also partner with a number of hospitals and pharmaceutical companies. That close association not only enriches the experience of our personnel but also creates an income stream that helps finance our research. Taken altogether, no less than 47% of the funding needed to carry out that research is obtained competitively. Of the remainder, 18% comes from, royalties, sales and licensing agreements with private sector entities. We remain strongly convinced that scientific research is everybody’s business and so have set up the CNIO Friends programme (Come and join with us!) that is making it possible for us to carry out more and more research initiatives. That is why we are constantly organizing educational programmes and events, and from time to time, even artistic initiatives.
Science is a big part of our common culture and so we want the CNIO to be a venue for stimulating people and ideas, together with an array of lectures and educational presentations, many of which are open to the public. The reason why is simple: a society that stays in contact with its culture, and so becomes more diverse, more egalitarian, is also a healthier society.
Olivia Newton John Cancer and Wellness Centre, Heidelberg, VIC, Australia
The Olivia Newton-John Cancer Wellness & Research Centre is a partnership between Austin Health and the Olivia Newton-John Cancer Research Institute. We are a comprehensive cancer centre, meaning we not only treat cancer but also carry out breakthrough research and clinical trials.
But we are more than that. Because we are a public hospital with a difference we put our patients at the heart of everything we do. This includes focusing on their minds and spirits and not just on their bodies.
We work to help patients live better with cancer and defeat it through our world class treatment, integrated research, leading clinical trials and tailored wellness programs.
In 1885, the ‘Austin Hospital for Incurables’ opened its first cancer ward and as early as the 1920s the use of x-rays in the treatment of cancer was being trialed at this location. By 1935 the Austin was the largest cancer hospital in Australia and in 1965 the Austin Hospital Clinical School was established, beginning the Austin’s reputation as a leading centre for medical education.
Today Austin Health treats more patients than any other hospital in the state of Victoria and is a leading treatment and research centre for a wide variety of conditions. These include issues related to spinal and head injuries, heart conditions, liver disease, stroke and epilepsy, aged care, urology, diabetes, thoracic disease, stress disorders and mental health, incorporating a specialized unit for children with eating disorders.
As a cancer thriver, Dame Olivia Newton-John drew strength from complementary therapies that improved her wellbeing and maintained her positive spirit. With a champion who has a commitment to care and wellbeing, it was only natural that wellness became the guiding principle behind our philosophy.
There has been a treatment centre on our site since Heidelberg House was opened in 1939. Fittingly, it was also the location of Zeltner Hall, which was opened in 1917 thanks to funds from philanthropist Meyer Zeltner. It was created as a venue for movies, performances and religious services for patients. The original plans for the design called for it to be ‘handsome in design’, and there was an emphasis on it providing a space to encourage positivity. This building is now, of course, our Wellness Centre and our philosophy of ‘handsome design’ and wellbeing continues 100 years later.
The ONJ Centre was first opened in 2012 as the result of a combination of government and philanthropic support, as well as donations from 200,000 members of the public totalling $17 million. From the outset, the concept of patient-centred comprehensive care was integrated into the structure itself. Wards sit metres from research labs and wellness was fundamental in guiding the design of the Centre. This comes together to create a space that supports patients and ensures that breakthrough research is trialled and applied effectively and efficiently.
University Hospitals Seidman Cancer Center, Cleveland, OHIO, United States
At University Hospitals Seidman Cancer Center, our team of caregivers provides the most advanced forms of cancer care, from prevention, screening and diagnosis through treatment and survivorship. Our single disease-focused teams design personalized cancer treatment plans for every patient who entrusts their care to us.
At University Hospitals Seidman Cancer Center in Cleveland, Ohio, we are leading the way in the diagnosis and treatment of cancer with state-of-the-art technology that allows our expert care teams to detect tumors earlier, target cancer cells more precisely, and perform complex procedures using minimally invasive techniques. Our patients have access to advanced cancer treatment options, ranging from our pioneering stem cell transplant program and immunotherapy to the first and only proton therapy center in northern Ohio. We also emphasize precision medicine that targets treatment to the unique genomic characteristics of a patient’s tumor.
The cancer experts at UH Seidman Cancer Center use a variety of tools to detect and diagnose cancer. Bloodwork and other lab tests, imaging technology (such as CT, MRI, PET and ultrasound) and biopsies are all used to diagnose cancer and determine the cancer’s stage (whether it has spread to other areas of the body.)
UH physicians also have access to state-of-the-art technologies for diagnosing cancer. For example, UH was the first hospital in the U.S. to use a PET/MRI scanner in a clinical setting, which uses positron emission tomography (PET) and magnetic resonance imaging (MRI) technology to generate enhanced digital images and accurately pinpoint cancer locations.
Our specialists use less invasive procedures, specialized state-of-the-art technologies, and other advanced techniques such as molecular biology and genomics in diagnosing cancer. Tools such as this lead to a more precise diagnosis, allowing for more targeted therapies to treat cancer.
Top 10 cancer hospitals in the world
Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute ‘where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied’. They bought a house on one of the canals in Amsterdam and named it the ‘Antoni van Leeuwenhoek Huis’, after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.
Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.
Modern day biomedical research depends on expensive equipment and techniques that can take years of practice to do well. Individual researchers need to use a wide range of techniques for their work. It is impossible for anyone to master them all or be given the money to buy all the equipment they are likely to need. The NKI has resolved this problem and used its funding in the most efficient way by creating dedicated centralized technology facilities that serve the whole Institute. All NKI scientists have direct access to these facilities. Most facilities have trained and dedicated operators that assist the researchers doing their experiments in one of the facilities. Periodic review of the facilities ensures that they maintain a high standard.
Genesis Cancer Care, Sydney, NSW, Australia
Genesis Care are 2,500 highly trained healthcare professionals and support staff across Australia, the U.K. and Spain, designing innovative treatments and care for people with cancer and heart disease.
We believe care should be focused on you, the individual, not the condition. We believe care should be available when and where you need it most and it should be designed to help give you the best life outcomes possible. This is our vision for your care.
At Genesis we work to develop a detailed understanding of your needs, so we can design the right care plan for you if you’re being treated for cancer, heart disease or sleep disorders. Across the world, we have more than 130 Genesis Care centres to help us bring you the right care. For radiation therapy, that includes 13 centres in the UK, 21 in Spain and 30 in Australia. We also offer cardiology and sleep services at more than 80 locations across Australia. Every year our team sees more than 160,000 people all over the world. Our purpose is to design care experiences that get the best possible life outcomes. To give you high-quality care that’s available where and when you need it and is tailored to your particular needs. Care that helps you get on with your life and do the things that are important to you. We do this by approaching care like nobody else. Everything we do is designed in partnership all the way through the entire care process. That means working with everyone from our clinicians to our technicians, from our internal teams to patients. Because, by working together, we stand a better chance of getting more complete health outcomes for you.
Peking University Cancer Hospital & Institute, Beijing, China
Peking University Cancer Hospital (three other titles — Beijing Cancer Hospital, Beijing Institute for Cancer Research, and Peking University School of Oncology — refer to the same entity) ranks among the China’s top academic cancer centers. Its physicians provide the highest quality of health care throughout the hospital and its faculty members responsible for translational research are respected for their dedication to teaching and training.
Peking University Cancer Hospital physicians provide patient-oriented medical services in a wide variety of cancer specialties treating gastric cancer, breast cancer, lung cancer, colorectal cancer, liver cancer, esophageal carcinoma, lymphoma, melanoma, and much more. Our team consists of a group of experts from different disciplines including oncology (cancer medicine), surgeons, radiology, and pathology.
At Peking University Cancer Hospital, research into the basic oncologic process and clinical investigation on specific cancer diseases go hand in hand. Investigations into cancer epidemiology, etiology, genetics, oncogenesis, pathogenesis and experimental therapeutics and many other fields keep Peking University Cancer Hospital at the forefront of biomedical research, driving the discoveries that lead to new ways to prevent and treat cancer. Within its 35 years commitment in cancer prevention and treatment, Peking University Cancer Hospital devotes major efforts to improving the health care for cancer patients. Now Peking University Cancer Hospital is one of the best cancer centers in China and a major source of discovery and development of more effective approaches to cancer prevention, diagnosis and treatment. Peking University Cancer Hospital also educates health care professionals and delivers medical advances to patients. Furthermore, Peking University Cancer Hospital is recognized for their scientific excellence and is awarded national funding through a rigorous peer review process. There are 301 doctors including 52 full professors and 84 associated professors specialized in treating various types and stages of cancers. With 790 beds, 28 clinical departments, 13 paramedical departments, and totally 24 wards, Peking University Cancer Hospital is a renowned cancer center in China devoted exclusively to cancer care, cancer education, and cancer research and cancer prevention.
Townsville Cancer Centre, Douglas, Queensland, Australia
The Townsville Cancer Centre is a tertiary cancer centre located at Townsville University Hospital that provides comprehensive cancer care to patients from across North Queensland.
In addition to the state-of-the-art cancer facility at Townsville University Hospital, the centre also provides specialist cancer services to patients in rural, remote and Indigenous communities using telehealth technology. We are committed to reaching as many patients as possible, and giving them the opportunity to be treated closer to their homes and support networks.
Our multidisciplinary teams include doctors, nurses and allied health professionals who meet regularly to plan treatment options for patients recently diagnosed with cancer and to review existing treatment plans during and after treatment. By working closely together, our clinicians can ensure they are providing the best possible care and treatment outcomes for our patients.
The Townsville Cancer Centre has a dedicated parking area and separate entrance to ensure ease of access for our patients. There is also a drop off and pickup area directly in front of the facility for patients.
The Townsville Hospital and Health Service provides a state-of-the-art cancer care service to both children and adults. Our clinicians provide treatment to all but the most complex adult cancers including: blood cancers, high-dose radiation therapy treatments and tele-oncology treatments to our remote communities, and specialized paediatric oncology. We are committed to continually developing our services so we can treat more patients, closer to their homes and support networks while ensuring our patients receive world-class care.
Hong Kong Adventist Hospital Oncology, Hong Kong
Blessed with Christian faith, this private hospital has been providing high quality healthcare to the local community, expatriates in Hong Kong and overseas patients who demand a higher standard of medical care. Thanks to its state-of-the-art equipment and highly-skilled staff, the Hong Kong Adventist Hospital – Stubbs Road offers all the advantages of a high-tech medical center where physicians and healthcare personnel provide patients with attentive care in a safe and comfortable environment.
In 2010, the hospital was awarded the accreditation certificate by the Australian Council on Healthcare Standards (ACHS). In 2014, the hospital received the accreditation for the second time from the ACHS. In addition, the hospital has also received full accreditation from the Trent Accreditation Board every year since 2000.
The Hong Kong Adventist Hospital – Stubbs Road is part of the Adventist Health global network of over 160 hospitals with the common goal of providing premiere “compassionate personalized care” to patients in all parts of the world.
It was in the late sixties that Dr. Harry Miller initiated the idea of building a hospital to serve the community and advance the philosophy of the Seventh-Day Adventist Church.With the help of two church missionaries, Pastor Ezra Longway and Pastor Robert Milne, they proposed to the Seventh-day Adventist Development Board to utilize the current location to build a hospital.Dr. Chan Shun, the founder and former Chair and Managing Director of Crocodile Garments Limited, gave the first million dollars. Donations soon flooded in, with the tireless effort of the hospital’s founders.
The Hong Kong Adventist Hospital – Stubbs Road has grown and developed in various specialties through the decades, but has remained a private, not-for-profit hospital. All revenues come from the provision of patient services.
For patients diagnosed with a serious illness, ensuring they receive appropriate care is a top priority. At the Hong Kong Adventist Hospital Oncology Center, our professional medical team strives to offer every patient comprehensive treatment. From diagnosis to treatment and rehabilitation, we work closely with patients to take care of all their physical, psychological and emotional needs. To achieve this, we have:
Institut Gustave Roussy, Villejuif, France
Living the future today
Gustave Roussy is the premier European Cancer Centre. It is a centre for patient care, research and teaching, and patients with all types of cancer can be treated there.
It looks to place innovation at the heart of a human, scientific and technological revolution in the fight against cancer.
We deploy cutting-edge research with the aim of making major discoveries, with our doctors we are establishing more individualized and less invasive medicine, we administer high quality treatment under the safest conditions, we are investing in the most modern technologies, we are developing innovative pathways to offer patients and their families well-being, good communication and help in these times of difficulty.
The Institute was founded as a result of the motivation of Professor Gustave Roussy, the father of the concepts of «cross-boundary working » and «multi-disciplinary patient management». For 70 years it has been developing an approach to oncology which remains faithful to its founder’s values: innovation, dynamism, cooperation and benevolence. All of this is built on the three guiding principles: patient care, research and teaching.
The integration of care, research and teaching
Gustave Roussy is a source of innovations in treatment and advances in diagnostic techniques. It employs an integrated approach to research, patient care and teaching in order to benefit the patient, and it brings together all the skills which are essential for top quality research in oncology. This encompasses basic research, clinical research and translational research to link the two.
High technology medicine in the service of mankind
The Institute has expertise in the management of rare cancers and complex tumours. It treats all cancers at every stage of life. It offers its patients individualized care combining innovation and a humane approach. The treatment is important but so is quality of life, physical, psychological and social.
Gustave Roussy is a hospital for specialist referral of complex cases and rare tumours. It can bring to bear skills in medical oncology, chemotherapy, radiotherapy, surgery, interventional radiology and reconstructive surgery.
Because of its commitment to teaching, Gustave Roussy remains in touch with and even anticipates advances in the discipline and so can predict the development of new specialties.
National Cancer Center, Japan
Founded as a hub for cancer treatment and research by the central government in 1962, the National Cancer Center has since lead the field. The Center was designated an Incorporated Administrative Agency in April 2010, then subsequently a National Research and Development Agency in April 2015, with a renewed commission to explore and address issues, complementing academia and the private sector. To serve as a nucleus of clinical research and development, the Hospital (Tsukiji campus) and Hospital East (Kashiwa campus) were designated as core hospitals for clinical research respectively in August and September of 2015, since then leading world class clinical research and investigator-initiated trials. It is essential to control cancer with both basic research as well as treatment, and it is our duty to form strategies and present to the nation and to the Japanese people.
Currently, one in every two Japanese citizens will develop cancer in their lifetime. Nearly one million people are newly diagnosed with cancer every year; and as the population is aging, we expect cancer patient numbers to build up. The mission of the National Cancer Center is not only to provide the best possible care including genomic medicine to each individual cancer patient, based on genomic and other clinical and biological information, but also to prevent the onset of cancer by identifying high-risk groups, developing and implementing effective prevention measures. In other words, we are to establish, practice and promote precision medicine tailored to individual patients. To achieve these objectives, it is essential to elucidate traits and diversity of cancer in individuals with integrated omics research including genomic analysis, and to develop optimal individual treatment and prevention methods. Developing an understanding of localized immune response in tumor tissue is also urgently called for.
The following has been our recent focus, in implementing the national Comprehensive 10-year Strategy for Cancer Control, in action from 2014, under the slogan “towards complete recovery from, prevention against, and dealing with cancer”:
- Reinforcing research and clinical systems to address unmet medical needs
- Developing a framework to provide optimized treatment and preemptive medical care for individual patients, based on genomic information
Following the revolutionary leap in genome sequencing technology, our nation is building the infrastructure to implement cancer genomic medicine into our national healthcare system. Our hospitals on both Tsukiji and Kashiwa campuses were designated as core hospitals for cancer genomic medicine in March 2018. It is imperative that we work with cancer genomic medicine cooperative hospitals across the nation, to ensure the delivery and quality of the new services, by sharing knowledge and nurturing specialists.
Experts at our two campuses are to integrate our insight and experience to advocate new cancer control strategies and policies. Collaboration with industrial and academic research institutions, to realize effective control over cancer is indispensable. The wishes and hopes of the Japanese citizens, including cancer patients and their families, need to be addressed, towards providing solutions. I, as President, wish to develop and reinforce a system for providing medical care that will allow all cancer patients and their families to keep their hopes alive.
Parkway Cancer Centre, Singapore
Cancer is a global epidemic of the modern world. Every year, millions of people are diagnosed with cancer, and millions more – their families, friends and loved ones – have their lives irrevocably altered. The silver lining of this reality is that constant advancements in medicines and medical technology are slowly but surely tipping the battle against cancer in our favour.
There is hope. And Parkway Cancer Centre is dedicated to sharing that hope to anyone and everyone affected by cancer.
We are home to a comprehensive suite of cancer treatments delivered by an experienced, multidisciplinary team of medical doctors, nurses, counsellors and other paramedical professionals. Every day, and for every patient, our team works hard to deliver holistic cancer care in a safe and soothing environment. They are aided by modern technologies and proven innovative therapies to achieve optimal clinical outcomes for our patients.
And since ensuring our patients’ wellbeing also means creating a comfortable experience for them each time, our guest relations officers and translators are always on-hand to greet and attend to them.
The battle against cancer is not an easy one, but through it all, we are there to support and guide our patients. We are here to give them hope.
Vall D’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO) is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer. Undertaking one of Spain´s most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of our patients.
Research at VHIO: translation toward precision oncology
Organized into four main programs: Preclinical, Translational, Clinical, and Core Technologies, VHIO´s team of some 300 researchers and physician scientists focus on understanding the fundamental biology of human cancer, from cellular and molecular biology and genetics through to therapeutics.
Its optimal organizational structure, coupled with its privileged location within the campus of the Vall d´Hebron University Hospital – affording direct access to patients as well as the entire spectrum of oncology professionals who care for them, allows VHIO to tackle the many unresolved questions in ultimately outsmarting the multifaceted, heterogeneous and complex disease that is cancer.
Standford Cancer Institute, California, United States
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
Designation as a Comprehensive Cancer Center signifies that the Stanford Cancer Institute maintains the highest level of scientific rigor, institutional support and coordination for the complete range of cancer-related research, including basic, translational, clinical and population-based science. The designation is recognition of the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The Institute’s mission is to support and coordinate the wide range of cancer-related activities — in basic, translational, clinical and population-based science — occurring at Stanford University, Stanford Health Care and Lucile Packard Children’s Hospital Stanford. Its over 450 members include scientists and physicians from a wide range of disciplines, all collaborating to translate research advances into improved cancer treatments.
The Stanford Cancer Institute (SCI) is one of only 49 NCI-designated Comprehensive Cancer Centers in the country. The SCI fosters an approach of thinking about the most challenging problems in cancer from a new perspective. Learn about our unique strengths in Genomics, Circulating Tumor DNA, Training the Next Generation of Physician Scientists, Phase I Clinical Research and Patient Care, Cellular Immunotherapy, Molecular Imaging and Radiation Therapy.
Oslo Comprehensive Cancer Centre, Oslo, Norway
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
The Institute is engaged in both basic and translational cancer research involving experimental research on model organisms from various evolutionary levels as well as human material from all types of cells and tissues. The co-localization with a large cancer hospital fulfils the premises for advanced medical research across sciences, a necessity towards the goals of individualized diagnostics and treatment for cancer patients.
Mazumdar Shaw Narayana Cancer Centre, Bengaluru, India
Mazumdar Shaw Cancer Centre (MSCC) situated at Narayana Health City is a comprehensive cancer centre with state-of-the-art technologies. The guiding principle of MSCC is in providing world-class health services in cancer to the masses at a cost which is affordable to all. The 607 bedded facility cancer centre is perhaps one of the largest cancer centres in the world with a unique commitment to provide world-class cancer care to everyone in need. MSCC is the largest comprehensive cancer centre. It is an excellence driven centre which offers multidisciplinary cancer care with a personalized touch to the patients from all corners of India, neighboring countries and all parts the world.
At Mazumdar Shaw Cancer Centre, a team of our experts from surgical oncology, radiation oncology, medical oncology, radiology, pathology, nuclear medicine and related disciplines come together in the Tumour Board meetings to discuss various cases and form a joint decision on the treatment plan. We believe that each patient and his/her disease is unique, hence our team of experts customize a ‘personalized treatment plan’. We constantly review and improve our protocols and encourage the participation of our patients as well as care givers to understand the disease and its treatment process. All cancer patients are discussed in the tumour board and a copy of decision shared with the patient. All site specific tumour boards take place on specific weekdays. This transpires into unbiased decision making for the patient and is also the forum where all the national and international guidelines are discussed at length relating to that particular patient. The general physicians from the community are also encouraged to attend the Tumour board so that they are a part of the decision making.
Check the best cancer hospitals in the world
BLK Cancer Centre, New Delhi
BLK Cancer Centre is one of the leading Centres in the country, offering comprehensive care to prevent and cure Cancer. The Centre is equipped with state-of-the-art technology, world-class facilities and a highly experienced team of Surgical, Medical and Radiation Oncologists who work in synergy to provide the best possible personalized care. Patients have access to the entire range of Cancer treatments, procedures and specialists, many of whom are internationally recognized experts in their field. The Centre has new technologies that have improved Cancer diagnosis and treatment, ensuring that the patients have access to the most recent and advanced Cancer Care.
BLK Cancer Centre has developed holistic strategies to prevent and cure Cancer by combining state-of-the-art technology and facilities with the latest advances in patient-focused treatment in a warm and supportive environment. The Centre brings into practice world-class expertise of clinicians on the most critical issues in cancer care, while Surgical Oncologists work side by side with Radiologists, Medical Oncologists and Reconstructive Micro Vascular Surgeons to ensure the most effective treatment. The Centre consistently invests in new technologies that have been shown to improve cancer diagnosis and treatment, ensuring that patients have access to the best care possible. Patients have access to the full complement of our specialists, many of whom are internationally recognized experts in their field.
BLK Cancer Centre is considered among the top cancer hospitals in India, majorly because of a few differentiating reasons, some of which are listed below.
State-Of-The-Art Facilities / Infrastructure / Technology: BLK Cancer Centre has developed holistic strategies to prevent and cure Cancer by combining state-of-the-art technology and facilities with the latest advances in patient-focused treatment in a warm and supportive environment.
The Centre consistently invests in new technologies such as advanced Robotic Surgical Interventions, Next Generation Image-guided Intensity-modulated Radiation Therapy- TomoTherapy, HDR Brachytherapy, facility for Total Body Irradiation etc. that has shown to improve cancer diagnosis and treatment.
Comprehensive Patient Care: The Centre was conceived to provide personalized and comprehensive Cancer Care with a patient-centric multidisciplinary approach. A team of highly qualified Medical Oncologist, Surgical Oncologist, Radiation Oncologist, Onco Pathologist, Radiologist and other allied specialists work seamlessly to ensure that the entire medical needs of the patients are handled meticulously. This ‘Combined Management’ approach optimizes patient care to a highly personalized level.
Tumour Board: The Tumour Board at BLK Cancer Centre plays a critical role in multidisciplinary Cancer Care. The team of specialists from Medical Oncology, Surgical Oncology, Radiation Oncology, Radiology, Genetics, Histo-pathology and Haemotology collaboratively offer most advanced patient care by reviewing each patient’s condition and determining the best treatment plan.
The Tumour Board focuses on every minute detail of patient care, evaluating all the treatment options and formulating the best treatment plan for the patient.
Community Outreach: BLK Cancer Centre had initiated a community outreach campaign– “Know Cancer – No Cancer” with an aim to provide people with easy access to high-end services, specialised treatment under the supervision of medical experts. The campaign was launched to make people aware of the symptoms and risk factors associated with cancer, importance of early detection and treatment to avoid associated risks with the disease.
The campaign has a wide outreach not only in Delhi- NCR but other adjoining cities of neighboring states such as Haryana, Punjab, U.P. and Uttarakhand. We have recently been honored with the Indian Healthcare Excellence Award for the Best Cancer Awareness Campaign.
University of Washington Seattle Cancer Alliance, Seattle, United States
Seattle Cancer Care Alliance represents a union of patients and doctors, physicians and researchers, care and cures in the pursuit of better, longer, richer lives for our patients.
Above all, we exist to move patients forward, past boundaries and toward hope, beyond fear and closer to discovery. SCCA is the intersection of compassion and hard science. Where a real difference can be made today and true progress happens tomorrow. This uniquely bold and inventive approach truly sets us apart.
We treat care differently. And, because of that, we see patients differently, too. Our care combines powerful science with devoted collaboration, where boundary-pushing discovery happens—care and science working together.
It is our fundamental belief that working in partnership with our patients is essential to who we are today and in the future.
Seattle Cancer Care Alliance (SCCA) is proud to be recognized as a nationally ranked hospital with top-ranked specialists in U.S. News & World Report’s 2019-20 “Best Hospitals” survey.
As the No. 1 cancer hospital in Washington state, SCCA is at the forefront of cutting-edge approaches to treatment and prevention, including the development of screening for pancreatic cancer, which was pioneered in Seattle. Early detection can result in significantly better outcomes for a cancer that is typically diagnosed at an advanced stage when the disease doesn’t respond well to treatment.
When Jeopardy host Alex Trebek announced in March that he had been diagnosed with pancreatic cancer, more than a few national media outlets reported that there is no way to screen for this type of cancer. It’s a misconception that has trickled down to the general public, including to Vince Scott, whose mother died of the disease in 2015.
Scott, 59, had a fatalistic attitude about his likelihood of developing pancreatic cancer. He knew he was at increased risk due to his mother’s diagnosis and an inherited genetic mutation that ups the likelihood of him developing both malignant melanoma and pancreatic cancer. There is widespread awareness that melanoma can be screened for, and Scott has been screened regularly by a dermatologist since he had his first melanoma removed when he was 22.
But he was dubious when his dermatologist told him that it’s possible to screen for pancreatic cancer. “I always thought there was nothing you could do,” says Scott, who lives in Lynnwood and works as a site manager for a construction company. “Knowing about something you can’t change had no appeal for me. If you can’t do anything about it, who wants to know how they’re going to die?”
But the turning point came last year when Scott finally bowed to the repeated urgings of his dermatologist, who had persuaded him to see a genetic counselor. The genetic counselor confirmed what his dermatologist had been saying: There is, in fact, a way to screen people at greater risk of developing pancreatic cancer. She referred him to Dr. Teri Brentnall, who had developed it.
Peter Maccallum Cancer Centre, Victoria, Australia
Peter Mac is one of the world’s leading cancer research, education and treatment centres globally and is Australia’s only public hospital solely dedicate
d to caring for people affected by cancer. We have over 2,500 staff, including more than 580 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.
Our cancer treatment and care services at our main centre are delivered in partnership with The Royal Women’s Hospital and The Royal Melbourne Hospital – all co-located within easy distance of one another.
While the majority of our care services are provided at Peter Mac, our patients may from time-to-time be referred to The Women’s and/or The Royal Melbourne hospital for particular treatments.
We ask that you please pay particular attention to your appointment letter, which will tell you where your appointment is located.
List of best cancer hospitals in the world
James Cancer Hospital & Solove Research Institute, Columbus, OHIO, United States
At The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), our vision is to create a cancer-free world, one person, one discovery at a time. This underlies everything we do in working to eradicate cancer through research that translates to innovative and highly targeted patient care.
The OSUCCC – James is the only cancer program in the United States that features a National Cancer Institute (NCI)–designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation’s largest public universities.
Cancer is no longer defined solely by stage and location, but rather by its biologic and genetic makeup. There is no routine cancer — it is different in each person. Working together and utilizing state-of-the-art facilities and technology, clinicians and researchers at Ohio State are speeding the development and delivery of treatments that target the molecules and markers fueling each person’s unique cancer.
At the Forefront of Research
The OSUCCC – James is one of only 51 NCI-designated comprehensive cancer centers in the nation, a designation that we have maintained through competitive renewal since 1976. After the site review for our most recent renewal, we earned the NCI’s highest ranking, “exceptional,” and received a five-year, $23 million NCI support grant. The NCI survey team stated that the OSUCCC – James “should serve as the model for other matrix university-based centers.”
At Ohio State, 293 cancer researchers and their teams from 11 of our 15 colleges work collaboratively, across multiple disciplines, to improve the effectiveness of cancer prevention, diagnosis and treatment.
Excellence in Cancer Care
In 1990, Ohio State opened the James Cancer Hospital and Solove Research Institute, the Midwest’s first freestanding cancer hospital, as the patient-care component of The Ohio State University Comprehensive Cancer Center. Ranked by U.S.News & World Report as one of the top hospitals in the nation for cancer care, the James Cancer Hospital and Solove Research Institute is one of only 11 DRG-exempt (diagnosis-related-group-exempt) or PPS-exempt (prospective-payment-system-exempt) institutions in the United States.
At Ohio State, we’ve helped pioneer the transdisciplinary, multimodality approach to cancer treatment and patient care. As a founding member of the National Comprehensive Cancer Network (NCCN), we help establish national guidelines and standards of cancer care.
The OSUCCC – James has more than 200 oncologists, each of whom specializes in just one type of cancer. That expert sub specialization leads to more productive integration with cancer research and, ultimately, to better outcomes. We manage hundreds of active or pending cancer clinical trials, many of which are initiated by OSUCCC – James investigators. Our genetic- and molecular-based research helps us understand each patient’s unique cancer and develop and deliver the targeted therapy that leads to better outcomes, fewer side effects and more hope.
Our disease-site groups combine the expertise of multiple disciplines and modalities including surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, nurses and researchers to provide patients with the latest in cancer detection, diagnosis, treatment and prevention. Patients are cared for by a team of experts who tailor a targeted treatment plan for each individual.
A model of excellence in patient care, the OSUCCC – James has achieved Magnet® designation as part of the American Nurses Credentialing Center (ANCC) Magnet Recognition Program®. This voluntary hospital recognition program is considered the highest honor an organization can receive for quality patient care and professional nursing practice. The OSUCCC – James is fully accredited by The Joint Commission, the American College of Surgeons Commission on Cancer and the Foundation for the Accreditation of Cellular Therapy.
MacArthur Cancer Service, Sydney, NSW, Australia
The Macarthur Cancer Therapy Centre (MCTC) opened in February 2003, providing cancer services to the adult population of Macarthur, Wollondilly and Wingecarribee. The centre offers Oncology Consultative Services, Chemotherapy, Radiation, Allied Health and Support Services.
The primary purpose of the SWSLHD Cancer Service is to provide timely, high quality, comprehensive and compassionate care to people within the Area who are affected by cancer and to those referred to our facilities and services for specialist care.
SWSLHD Cancer Services is at the leading edge of cancer treatment and research in Australia. These facilities provide comprehensive Oncology consultative services, as well as Specialty Surgery, Radiation treatment, Chemotherapy, Palliative Care, Haematology, Cancer Genetics and Psychology services.
Integrated multidisciplinary teams specialise in high activity tumour groups, currently in the areas of Breast, Gynaecology, Haematology, Head and Neck, Genito-Urinary, Lung, Colorectal, Upper Gastro-Intestinal and Neurology.
We have a full schedule of support programmes for families, carers and staff, as well as education materials for specific tumour groups, and supportive care pathways.
Horizon Cancer Centre, Bumrungrad Hospital, Bangkok, Thailand
The Horizon Regional Cancer Center at Bumrungrad International Hospital in Bangkok, Thailand provides comprehensive cancer care and treatment by a multidisciplinary team of cancer specialists, including preventionm, diagnosis, treatment, assessment of treatment plan and management of possible complications, emotional support, nutritional care, pain management, and close monitoring of possible recurrence.
1. Treatment of Cancer
- Assessment of patient’s health and treatment planning
- Chemotherapy drug administration
- Targeted therapy
- Blood/platelet transfusion
- Radiation therapy
- Assessment of patient’s health and treatment planning
- Radiation therapy
- Non-cancerous conditions
- Volumetric-modulated arc therapy (VMAT)
- Hematopoietic stem cell transplantation (HSCT)
- Assessment of patient’s health and treatment planning
- Hematopoietic stem cell transplantation to treat leukemia, lymphoma, aplastic anemia, and bone marrow cancer
- Peripheral blood stem cell transplantation (PBSCT)
- Bone marrow transplantation (BMT)
2. Cancer screening
- Pap smear
- Low-dose CT scan
3. Other services
- Testing for tumor markers and carrying out biopsies in a laboratory that meets international standards
- Care of colostomy
- Care of implanted venous access device (port-a-cath)
- Nutrition consultation
- Psychological support
- Palliative care of terminally ill patients
- Cancer support group
- Provide information and organize seminars about cancer
Dharamshila Narayana Cancer Hospital, New Delhi
Dharamshila Hospital And Research Centre (DHRC) has collaborated with Narayana Health and the new name of our hospital is Dharamshila Narayana Superspeciality Hospital (A unit of Dharamshila Cancer Foundation And Research Centre).
Dharamshila Narayana Superspeciality Hospital (A unit of Dharamshila Cancer Foundation And Research Centre) is a State-of-the-Art multispeciality hospital with world class medical infrastructure and an Expert Team of Highly Skilled Superspecialists providing Comprehensive Medical Care in Several Specialities including Oncology, Cardiology, Neurology, Urology, Gastroenterology, and Orthopaedics. Long legacy of trust, more than two decades of experience and Innovative Treatment Approaches has made our hospital a leading and preferred destination for medical treatment in India.
Few Pioneering Steps into the credit of Dharamshila Narayana Superspeciality Hospital (A unit of Dharamshila Cancer Foundation And Research Centre) is North India′s First Cancer Hospital commissioned in 1994 with 300 beds, with the same objective of making Cancer Care Available, Accessible and Affordable. Dharamshila Hospital is First Cancer Hospital of India to get NABH Accreditation in 2008 for providing quality healthcare services. Our Laboratory Services are also accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL). Dharamshila Narayana is the first hospital in India, given accreditation by National Board of Examination (NBE) for the Diplomate National Board (DNB) Programme in medical and surgical oncology.